Sarepta Therapeutics,, Inc. (SRPT)
NASDAQ · Manufacturing · Pharmaceutical preparations
$18.88+$0.4899 (+2.66%) on the dayAs of the close; data may be delayed.
SRPT price, last 12 months
Key stats
- Previous close
- $18.39
- Open
- $18.88
- Day range
- $18.00 – $18.94
- 52-week range
- $14.68 – $25.32
- Volume
- 1.9M
- Avg volume (20 days)
- 3.1M
- Market cap
- $2.0B
Performance
1W−6.1%
1M−3.0%
3M+12.1%
6M−12.9%
YTD−12.3%
1Y+3.4%
vs S&P 500, 1Y−13.4 pts
Technicals and fundamentals
About Sarepta Therapeutics,, Inc.
Sarepta Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, gene therapies, and other genetic medicines for rare diseases, particularly neuromuscular disorders. The company has developed approved treatments for Duchenne muscular dystrophy, including EXONDYS 51, VYONDYS 53, AMONDYS 45, and ELEVIDYS, and is advancing additional therapeutic candidates for neuromuscular and other rare diseases. The company operates in one segment: discovering, developing, manufacturing, and delivering therapies to patients with rare diseases.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $2.0B